Inventor
KEISUKE IMAMURA
Inventor
JP
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes27%
C07BGeneral methods of organic chemistry4%
PatentTitleYear
12,421,188Heterocyclic compound and use thereof202512,415,782Heterocyclic compound and use thereof202512,404,237Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1'-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives202512,091,410Heterocyclic compound202412,071,434Heterocyclic compound202411,655,241Heterocyclic compound and use thereof202311,440,883Heterocyclic compound and use thereof202211,390,634Fused heterocyclic compound202211,319,286Heterocyclic compound and application thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to TAKEDA PHARMACEUTICALS CO (9)· patent assignee history
2022–2025Based in JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICALS CO | 9 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 9 | 2022–2025 |